Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trial
— TDAHEC2Official title:
Cognitive Training in Children With Attention Deficit Hyperactivity Disorder (ADHD)
NCT number | NCT02560454 |
Other study ID # | K140706 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2016 |
Est. completion date | February 2019 |
Verified date | February 2018 |
Source | Assistance Publique - Hôpitaux de Paris |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
ADHD is associated with cognitive deficit. Therefore, cognitive training is often proposed as
an intervention for ADHD that targets cognitive deficits, with specific exercises through
intensive training sessions. This intervention is based on principles of brain plasticity and
cerebral functional reorganizations.
Working memory deficits constitute a key impairment in ADHD. That is why, Cogmed working
memory training is the most commonly used and studied cognitive training program in clinical
practice and research. It is clear from most studies that Cogmed training program increases
working memory in ADHD. However, transfer of learning is not demonstrated on: other cognitive
functions that are not targeted by the program, on ADHD symptoms, nor on academic
achievement.
In addition to this type of intervention multi-factorial program targeting different
cognitive function as Presco also exist but have been less studied.
To address these challenges, this study will follow a randomized and controlled design.
The main objective of this study is to examine the impact of cognitive training in comparison
with a control waiting-list group among children with ADHD on:
1. ADHD symptoms,
2. cognitive functioning,
3. attentional capacities
4. academic achievement.
The second objective is to compare two types of cognitive training a unifactorial program
Cogmed targeting working memory and a multifactorial Presco focusing on different cognitive
functions affected by ADHD.
Long-term effects are examined six months after training. Participants (n=90) will be
randomly assigned to the two experimental group (Cogmed or Presco) or to the control group
waiting list. Participants will be evaluated three time (time 1) just before the
intervention, (time 2) six weeks after the first evaluation, immediately after the
intervention and (time 3) six months after the intervention.
Status | Completed |
Enrollment | 83 |
Est. completion date | February 2019 |
Est. primary completion date | September 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 12 Years |
Eligibility |
Inclusion Criteria: - age = 8 et = 12, (2) - ADHD diagnostic according to DSM IV or V criteria, - score between 28 to 40 for The ADHD-RS, - IQ-score, non-verbal reasoning (WISC-III or IV) =80, verbal reasoning (WISC-III or IV) =80, - have internet and a computer at home, - if methylphenidate treatments must not be changed for six months, (7) written consent by legal guardian. Exclusion Criteria: - Participant taking other medication than methylphenidate won't be included. - Participant suffering from another neurological disorder than ADHD won't be included |
Country | Name | City | State |
---|---|---|---|
France | Amsellem | Paris |
Lead Sponsor | Collaborator |
---|---|
Assistance Publique - Hôpitaux de Paris |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The ADHD Rating Scale IV (ADHD RS) | 6 weeks | ||
Secondary | ADHD Scale | symptoms and psychopathology associated | 6 weeks and 6 months | |
Secondary | TEA-Ch and Continuous Performance Test | Attentional capacities | 6 weeks and 6 months | |
Secondary | Behavior Rating Inventory of Executive Function (BRIEF) | Cognitive functioning | 6 weeks and 6 months | |
Secondary | Wechsler Test (WIAT-II CDN-F) | Academic achievement | 6 weeks and 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03260205 -
Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03546400 -
Safety, Tolerability and PK Study of Methylphenidate HCl ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02917109 -
LearningRx Cognitive Training for ADHD
|
N/A | |
Completed |
NCT02248948 -
Superiority of Omega-3 Versus Placebo on the Improvement of ADHD in Children
|
N/A | |
Recruiting |
NCT01750307 -
The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment)
|
N/A | |
Recruiting |
NCT06170996 -
Internet-Assisted Behavioral Parent Training Intervention for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00735371 -
Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Withdrawn |
NCT03580005 -
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
|
Phase 4 | |
Completed |
NCT02578030 -
Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD
|
Phase 1 | |
Completed |
NCT02574273 -
Pilot Trial of a Social Skills Group Treatment (Secret Agent Society Program)
|
N/A | |
Completed |
NCT02257216 -
Vayarin® Medical Food Study for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Recruiting |
NCT04943796 -
A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life
|
||
Recruiting |
NCT04634006 -
Home-Based tDCS in Children With ADHD: A Randomized, Sham-Controlled tDCS and fNIRS Study
|
N/A | |
Active, not recruiting |
NCT02908802 -
Probiotic Supplement as Treatment for Students With ADHD
|
N/A | |
Completed |
NCT02604407 -
Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)
|
Phase 3 | |
Completed |
NCT05870605 -
Drug Use Study With Intuniv® in European Countries
|
||
Terminated |
NCT03481959 -
Effectiveness of Methylphenidate Late Formula to Reduce Cannabis Use in Young Cannabis-Related Patients and Attention Deficit Disorder Hyperactivity
|
Phase 3 | |
Terminated |
NCT03638466 -
Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder
|
Phase 2 | |
Completed |
NCT03709940 -
Brain Connectivity in Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT02795637 -
Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction
|
Phase 1 |